GLP-1 Weight Loss Treatment in Houston
Physician-guided consultations and individualized weight management at Doctors Clinic Houston.
Our Weight Loss Therapy program uses a personalized medical approach, with treatment options including GLP-1 injections when medically appropriate. Your physician evaluates your health profile, goals, existing conditions, and current medications before recommending a plan.
GLP-1-based medicines are not appropriate for everyone. A consultation helps determine eligibility and does not guarantee a prescription or a particular medication.

How GLP-1 and Related Medicines Work
GLP-1 receptor agonists act on pathways involved in appetite and blood-sugar regulation. Certain medicines are FDA-approved for chronic weight management in eligible patients. Treatment decisions require medical evaluation, consideration of possible side effects, and follow-up.
Tirzepatide, Mounjaro, and Zepbound
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is the active ingredient in both Mounjaro, approved for type 2 diabetes, and Zepbound, approved for chronic weight management in eligible patients. These brand names refer to products containing the same active ingredient but with different approved indications. Mentioning these medications does not mean that every brand or formulation is available at Doctors Clinic Houston. Confirm specific medication availability and suitability directly with the clinic.
1. Medical Evaluation
Review medical history, weight-related conditions, current medications, and treatment goals.
2. Individualized Options
Discuss nutrition, activity, and appropriate medication-assisted treatment options based on your evaluation.
3. Ongoing Follow-Up
Review progress, tolerability, side effects, and any adjustments recommended by your physician.
Who May Be Eligible?
Eligibility depends on the specific medicine, BMI, weight-related conditions, medical history, contraindications, and prescribing guidelines. A physician can review your circumstances and discuss alternatives if medication is not suitable.
Risks and Safety Considerations
Potential side effects of GLP-1-based medicines include nausea, vomiting, diarrhea, constipation, and other digestive symptoms. Some medicines also carry important warnings involving the pancreas, gallbladder, certain thyroid tumor histories, pregnancy, and other circumstances. Your physician should review the specific prescribing information and precautions.
Start with a Medical Consultation
Discuss whether GLP-1 or related treatment options may fit your personalized weight-management plan.
Frequently Asked Questions
The clinic’s doctor-approved Weight Loss Therapy information identifies GLP-1 injections among its treatment options. Your physician determines suitability after an individualized evaluation.
Tirzepatide is the active ingredient in both Mounjaro and Zepbound, which have different FDA-approved indications. Availability of either brand should be confirmed with the clinic.
A prescription is not guaranteed. Treatment decisions depend on your evaluation, clinical needs, and medication-specific eligibility and safety requirements.
Medical weight management can include nutrition, movement, sleep, and ongoing follow-up as part of a comprehensive approach.
For the broader program, see our Weight Loss Therapy page. Prescription medicines require medical supervision; treatment results vary and are not guaranteed.